Comparative Effectiveness and Safety of Oseltamivir, Baloxavir, and Peramivir in Children with Influenza A/B: A Propensity-Matched Cohort Study
Background: Comparative evidence on pediatric influenza antivirals is limited. We compared clinical features of influenza A and B and evaluated oseltamivir, baloxavir marboxil, and peramivir. Methods: Retrospective cohort of 3,718 children (A, n=1,717
Authors
- Lin Wang (ORCID: https://orcid.org/0000-0001-5536-781X)
- Zongshuan Duan
- Yan‐ning Qu (ORCID: https://orcid.org/0000-0001-8111-9705)
- Mengyi Sheng
- Jing Yuan (ORCID: https://orcid.org/0000-0002-6939-9676)
- Hui Wang (ORCID: https://orcid.org/0000-0003-0086-5795)
- Linying Guo (ORCID: https://orcid.org/0000-0002-4138-996X)
- Jinghua Cui (ORCID: https://orcid.org/0000-0001-8427-7784)
Institutions
- Capital Institute of Pediatrics (CN)
Publication Details
- Published
- 2025-10-09
- DOI
- https://doi.org/10.22541/au.175998998.89076235/v1
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00